28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.
Humalog, for instance ... where it detailed how it would cut the list price of its Lantus product by 78%, as well as establishing a $35 cap on out-of-pocket costs for Lantus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback